3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Agnosia
2
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Parathyroid Neoplasms
1
Parathyroid Diseases
1
Pain, Postoperative
1
Opioid-Related Disorders
1
Neoplasms
1
Mucositis
1
Goiter
1
Cancer Pain
1
Brain Neoplasms
1
Interventions
Bupivacaine
18
Ropivacaine
10
Saline Solution
9
Dexmedetomidine
9
Sodium Chloride
5
Pregabalin
5
Morphine
5
Ketamine
5
Lidocaine
4
Dexamethasone
4
Control Groups
4
Analgesia, Patient-Controlled
4
Tea
3
Gabapentin
3
Anesthetics, Local
3
Acetaminophen
3
Population Groups
2
Parapsychology
2
Magnesium Sulfate
2
Injections, Epidural
2
Fentanyl
2
Dental Occlusion
2
Anti-Inflammatory Agents, Non-Steroidal
2
Analgesics, Opioid
2
thiamine triphosphorate
1
ramosetron
1
parecoxib
1
gamma-Aminobutyric Acid
1
esmolol
1
Water
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pain, Postoperative
×
Tramadol
×
Clear all
NCT00519246
2009-03-31
COPTEAM
Nanjing Medical University
Phase 4
Completed
2,000 enrolled